Products
Research Areas
COVID-19
Resources
Contact Us
Distributors
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us
LSBio
2401 Fourth Avenue Suite 900
Seattle WA 98121
Phone:
866-819-4732 (Toll Free North America
206-374-1102 (International)
Fax:
866-206-6909 (Toll Free North America)
206-577-4565 (International)
How To Buy - Details about how to buy our products.
Orders@LSBio.com - To submit a new order.
Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability, bulk quotes, Proforma invoice requests, or other billing issues.
Technical.Support@LSBio.com - To request technical information about an LSBio product or its applications
Sales@LSBio.com - To request information about distribution agreements, or general business development.
Worldwide Distributors List - To find your local distributor if you're not within the United States.
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C40990-100 100 µg (0.5 mg/ml) $314 
TNFRSF10B / Killer / DR5 Antibody - Human peripheral blood lymphocytes stained with purified DJR2-2, followed by biotinylated anti-mouse IgG and Sav-PE

Monoclonal Mouse anti‑Human TNFRSF10B / Killer / DR5 Antibody (clone DJR2‑2 (2‑6), Extracellular Domain) LS‑C40990

Monoclonal Mouse anti‑Human TNFRSF10B / Killer / DR5 Antibody (clone DJR2‑2 (2‑6), Extracellular Domain) LS‑C40990

Antibody:
TNFRSF10B / Killer / DR5 Mouse anti-Human Monoclonal (Extracellular Domain) (DJR2-2 (2-6)) Antibody
Application:
Flo
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$314
LS-C40990-100
Toll Free North America
866-819-4732
For Research Use Only

Overview

Antibody:
TNFRSF10B / Killer / DR5 Mouse anti-Human Monoclonal (Extracellular Domain) (DJR2-2 (2-6)) Antibody
Application:
Flo
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
DR5 antibody LS-C40990 is an unconjugated mouse monoclonal antibody to human DR5 (TNFRSF10B / Killer) (Extracellular Domain). Validated for Flow. Cited in 1 publication.
Target
Human TNFRSF10B / Killer / DR5
Synonyms
TNFRSF10B | Cytotoxic TRAIL receptor-2 | CD262 antigen | DR5 | Death receptor 5 | KILLER | TRAIL-R2 | TRICK2B | TRAILR2 | TRICK2A | TRICKB | TRICK2 | CD262 | Fas-like protein | TRAIL receptor 2 | ZTNFR9
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
DJR2-2 (2-6)
Conjugations
Unconjugated
Purification
Affinity purified
Modifications
Unmodified
Immunogen
Recombinant human TNFRSF10B / DR5.
Epitope
Extracellular Domain
Specificity
Extracellular domain of DR5-human IgG1 Fc fusion protein
Applications
  • Flow Cytometry
Presentation
Phosphate-buffered solution, pH 7.2, 0.09% sodium azide.
Storage
Store at 4°C. Avoid freezing.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About TNFRSF10B / Killer / DR5
O14763 NM_147187 Q6FH58

LSBio Ratings

TNFRSF10B / Killer / DR5 Antibody (Extracellular Domain, clone DJR2-2 (2-6)) for Flow LS-C40990 has an LSBio Rating of
Publications (4)

Publications (1)

Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Shi J, Tricot GJ, Garg TK, Malaviarachchi PA, Szmania SM, Kellum RE, Storrie B, Mulder A, Shaughnessy JD, Barlogie B, van Rhee F. Blood. 2008 111:1309-17.

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 9/27/2021